HPLC–MS Characterization of 99.5% Pure Compounds Using Miniaturized Mass Detector
Special Issues
Detecting impurities in any chemical reaction is becoming increasingly important to detect those present at low levels (for example, 0.5%).
Detecting impurities in any chemical reaction is becoming increasingly important to detect those present at low levels (for example, 0.5%). Common methods of assessing purity include chromatography with a detector, such as an ultraviolet (UV) light detector, or an evaporative light scattering detector (ELSD). However, these detectors do not give any information about the molecular weight or structure of the impurities detected and thus make identification difficult.
A complementary detector, which can be used with a chromatograph, is the mass spectrometer (MS). Traditional MS systems available are too bulky, expensive to purchase and run, and power hungry for use in every laboratory. These limitations have lead to compromises in the choice of chromatography detectors that can be used in synthetic laboratories.
The Microsaic 4000 MiD® gives the chemist the ability to have a simple-to-use, low cost mass detector at the bench. The system is portable and modular so it can be easily integrated into a wide range of bench-top applications.
Here we report on how the Microsaic 4000 MiD® can be used as an HPLC detector to identify the presence of impurities that would otherwise be lost using popular detection methods.
Methods
Table I show the HPLC–MS conditions used for the impurity characterization.
Test samples were prepared, with the major component at 1 mg/mL and the minor one at 5 µg/mL (0.5% w/w). Two samples were prepared. Test sample A was made up by mixing Verapamil at 1 mg/mL and Bromopride at 5 µg/mL (0.5% w/w). Test sample B was Cortisone (1 mg/mL) and Verapamil (5 µg/mL–0.5% w/w).
Results and Discussion
Well Resolved Impurities
Test sample A contains two well resolved compounds, Bromopride and Verapamil, with the minor component eluting first. Both compounds are visible in the total ion chromatogram (TIC) shown in Figure 1. The mass spectra of the two chromatographic peaks confirmed the presence of bromopride and verapamil with m/z 344.4 and m/z 455.4, respectively.
Figure 1: Total ion chromatogram for test sample A.
Co-Eluting Impurities
Test sample B is an example of two compounds that coelute and could not be distinguished by UV only. Figure 2 shows the TIC and UV data of the cortisone–verapamil test mix. As expected, this shows a single major UV and TIC peak. When analyzing the TIC, mass spectra data are dominated by the cortisone ion, but the one from the tail of the peak shows an ion corresponding to verapamil.
Figure 2: Combined total ion and UV chromatograms of test sample B.
Conclusions
The Microsaic 4000 MiD® coupled to a HPLC enabled the identification of unknown impurities down to the low level of 0.5% (w/w) in full scanning mode. In the case of coelution on the HPLC system, the 4000 MiD® could help to identify an impurity where the UV data would provide misleading results.
Microsaic Systems plc
GMS House, Boundary Road, Woking, Surrey, UK
New Study Uses MSPE with GC–MS to Analyze PFCAs in Water
January 20th 2025Scientists from the China University of Sciences combined magnetic solid-phase extraction (MSPE) with gas chromatography–mass spectrometry (GC–MS) to analyze perfluoro carboxylic acids (PFCAs) in different water environments.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ion used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
A Guide To Finding the Ideal Syringe and Needle
January 20th 2025Hamilton has produced a series of reference guides to assist science professionals in finding the best-suited products and configurations for their applications. The Syringe and Needle Reference Guide provides detailed information on Hamilton Company’s full portfolio of syringes and needles. Everything from cleaning and preventative maintenance to individual part numbers are available for review. It also includes selection charts to help you choose between syringe terminations like cemented needles and luer tips.
The Complexity of Oligonucleotide Separations
January 9th 2025Peter Pellegrinelli, Applications Specialist at Advanced Materials Technology (AMT) explains the complexity of oligonucleotide separations due to the unique chemical properties of these molecules. Issues such as varying length, sequence complexity, and hydrophilic-hydrophobic characteristics make efficient separations difficult. Separation scientists are addressing these challenges by modifying mobile phase compositions, using varying ion-pairing reagents, and exploring alternative separation modes like HILIC and ion-exchange chromatography. Due to these complexities, AMT has introduced the HALO® OLIGO column, which offers high-resolution, fast separations through its innovative Fused-Core® technology and high pH stability. Alongside explaining the new column, Peter looks to the future of these separations and what is next to come.
Oasis or Sand Dune? Isolation of Psychedelic Compounds
January 20th 2025Magic mushrooms, once taboo, have recently experienced a renaissance. This new awakening is partially due to new findings that indicate the effects of psilocybin, and its dephosphorylated cousin psilocin may produce long lasting results for patients who might be struggling with anxiety, depression, alcohol and drug abuse, and post-traumatic stress disorder. Hamilton Company has developed a methodology for the isolation and identification of 5 common psychedelic compounds used in the potential treatment of disease. The PRP-1 HPLC column resin remains stable in the harsh alkaline conditions ideal for better separations.
